戻る Agenda
[V6-S3] The Way toward Commercialization, Regenerative Medical Products
Session Chair(s)
Yoji Sato, PHD
Deputy Director General, National Institute of Health Sciences, Japan
The long way is lying from the discovery of regenerative medical seeds toward the commercialization. In this session, hot topics in academia study and current development case in company will be presented. And also, the considering points in clinical trial of approved regenerative medical products from reviewer point of view will be explained. The issues emerging in the various development stages will be identified and the solutions will be explored through the lectures and panel discussion.
Speaker(s)
Ichiro Sekiya, MD, PHD
Professor, Tokyo Medical and Dental University, Japan
Challenge from Academia to Remove Knee Pain by Regenerative Medicine
Setsuko Hashimoto, PHD
President and CEO, CellSeed Inc., Japan
Developing Regenerative Medicine using Cell Sheet Engineering
Yoshiaki Maruyama, PHD
Review Director, Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Safety and Efficacy Evaluation of Regenerative Medical Products